ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 108 filers reported holding ENZO BIOCHEM INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $43,000 | -33.8% | 7,880 | -0.6% | 0.01% | -50.0% |
| Q4 2017 | $65,000 | -21.7% | 7,925 | 0.0% | 0.02% | -25.0% |
| Q3 2017 | $83,000 | -4.6% | 7,925 | 0.0% | 0.02% | +14.3% |
| Q2 2017 | $87,000 | -53.7% | 7,925 | -64.7% | 0.02% | -53.3% |
| Q1 2017 | $188,000 | -87.9% | 22,420 | -90.0% | 0.04% | -88.4% |
| Q4 2016 | $1,554,000 | +35.2% | 223,931 | -0.8% | 0.39% | +34.8% |
| Q3 2016 | $1,149,000 | +114800.0% | 225,834 | +126064.2% | 0.29% | – |
| Q1 2015 | $1,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |